(주)삼양바이오팜 · SAMYANG BIOPHARM CORPORATION
Last · —$40600.00-2600.00 (-6.02%)live · yahoo · 0s ago
Market cap——
P/E · TTM135fwd — · eps —
Beta—vs S&P 500
Div yield—annual · TTM
52w range
——
Volume—session
| Revenue | ₩28.6B |
|---|---|
| Operating income | ₩2.7B |
| Net income | ₩2.2B |
| Free cash flow | ₩3.0B |
| Operating margin | 9.4% |
| Net margin | 7.8% |
| Return on equity | 1.0% |
| Period | 2025 |
Loading chart…
Documents
FormReporting forFiledFlags